Metoclopramide. An updated review of its pharmacological properties and clinical use.
about
The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pigWhole bowel irrigation as a gastrointestinal decontamination procedure after acute poisoningMechanism of action for N-substituted benzamide-induced apoptosisEffects of i.v. metoclopramide, atropine and their combination on gastric insufflation in children anaesthetized with sevoflurane and nitrous oxide.Pharmacokinetics of metoclopramide in patients with liver cirrhosis.Comparison of the effect of cisapride and metoclopramide on morphine-induced delay in gastric emptying.Effects of migraine attack and metoclopramide on the absorption of tolfenamic acid.Pharmacotherapy of postoperative nausea and vomiting.Birth outcome following maternal use of metoclopramide. The Euromap study group.Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in miceInsights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.RETRACTED: Prevention of nausea and vomiting during termination of pregnancyRETRACTED: Management of postoperative nausea and vomiting in women scheduled for breast cancer surgery.Nasal route: an alternative approach for antiemetic drug delivery.5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders.The management of postoperative nausea and vomiting: current thoughts and protocols.Drug safety in acute migraine treatment.Efficacy of a scheduled IV cocktail of antiemetics for the palliation of nausea and vomiting in a hospice population.Comparative central nervous system effects and pharmacokinetics of neu-metoclopramide and metoclopramide in healthy volunteers.Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study.Pharmacotherapy and the neurobehavioural sequelae of traumatic brain injury.Pharmacologic treatment of chemotherapy-induced nausea and vomiting.Interaction of insulin with prokinetic drugs in STZ-induced diabetic mice.Sinus arrest after administration of intravenous metoclopramide.Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation.Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesisEffect of metoclopramide on portal blood flow in patients with liver cirrhosis, measured by the pulsed Doppler system.Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients.Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation.Fenoldopam: effect on aldosterone secretion.N-substituted benzamides inhibit NFkappaB activation and induce apoptosis by separate mechanisms.Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism.Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.Pharmacokinetics of metoclopramide in neonates.Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.Atrial natriuretic factor inhibits metoclopramide stimulated aldosterone release in man.The effect of metoclopramide on mefloquine pharmacokinetics.In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.A comparison of the gastric and central nervous system effects of two substituted benzamides in normal volunteers.Metoclopramide-induced supersensitivity psychosis.
P2860
Q24681951-9DD531DB-40BA-4A4D-969E-352AD697F590Q28294901-22A5A5BE-EC06-40AC-B33B-3D6B7E4B50E7Q30832096-5E4840A8-A964-490C-8199-3631BF0FD1CEQ32155723-6A3F991E-20B9-4953-B4B1-A077FE86E641Q34358153-AE2DFF93-C556-4C60-B726-88716083235FQ34418192-1AA1052C-6462-45C9-9DE9-978F56250D5FQ34620805-14E7A4A6-106C-4500-B083-18311C9B27FEQ35095182-5AB639EF-9FA7-400D-9626-6B617C5EABEFQ36055092-1241556F-D3FA-4B30-83DF-96D4A991CA8EQ36178704-1BFFC981-5B10-4128-999A-0F46DE4620CEQ36497020-1FB0D9E9-8E5F-4FFE-B7F2-CFD292547681Q37769654-58EAFA23-008C-45CA-8BC5-52BF741ECEADQ37941476-81BD5AC2-1EC9-4C07-91D5-1A32F5967AAAQ37946545-C12E9C75-7127-46EF-B485-C62F12D3830CQ37953385-9DBF87E9-8A1D-4F97-A082-7C72195C2F8CQ38089612-68089824-EBC3-4BFA-A83F-D7DCA9552BFEQ38378898-B3131B3D-EF48-49EE-8F2D-6BCD343EA89BQ39318044-4E4B7D88-85F7-4DB4-98E8-4FBCA4EC20C3Q39457418-E1B04B76-AE9B-4A89-8C4C-EA6FF966A519Q39482770-B13B5AFE-218B-44D2-8A55-25FACB86BFD6Q39524746-154C1438-3F89-40D1-890A-AA5B215E2944Q40078863-4A045B22-DC55-4940-AB11-C1B8421CA7B4Q40400795-05DA59FF-7E23-4B22-A33A-ED24698FDAA4Q40458980-71B03832-516C-496F-8018-67CA583BDECFQ41128422-A2942537-7570-4BA9-9B6D-691710D38641Q41159971-0B4F7768-DB66-4EC4-AC99-B2B3C5778D3FQ41215946-D773E967-7197-4122-8638-91A46F7ADA0BQ41338264-7C139A61-43A1-409D-9A51-3BE814BE761EQ41449540-30E80451-3CF4-406B-B345-3E7DCBF20C50Q41857537-E5AB48FF-8CFB-4453-98ED-566834471C58Q41916472-1B191AEC-D483-429E-BE1F-ABA0ABFAFABEQ42037926-F972C112-6761-450F-AA6F-0A55A6D16539Q42180755-F845E1C4-39F6-4FD2-BF18-0D93B45F745AQ42676125-41B7EF3D-4FB5-456E-8179-9DC1FE5418D2Q42850031-49B32EE8-0242-41ED-9CCD-06E51833E00CQ43205002-F0EC412C-BFE2-445F-A140-810827A740FEQ43205192-FB5B9335-0ACB-4857-BD16-A9B4E605C030Q43230834-03CA572C-5684-431A-99BB-6DECD6ABFC85Q43240475-1B51A357-0DD0-4A15-BBFE-C140F060BB1EQ44114532-02FA8FD3-47C2-4ED7-B8F2-687525FA595A
P2860
Metoclopramide. An updated review of its pharmacological properties and clinical use.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Metoclopramide. An updated review of its pharmacological properties and clinical use.
@en
type
label
Metoclopramide. An updated review of its pharmacological properties and clinical use.
@en
prefLabel
Metoclopramide. An updated review of its pharmacological properties and clinical use.
@en
P2093
P1433
P1476
Metoclopramide. An updated review of its pharmacological properties and clinical use.
@en
P2093
C W Hamilton
J A Linkewich
J A Romankiewicz
R A Harrington
P304
P356
10.2165/00003495-198325050-00002
P577
1983-05-01T00:00:00Z
P6179
1005501925